Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
MYCN
REST API REST API
Homo sapiens
MYCN is differentially expressed in 262 experiments: 132 organism parts: brain, kidney, ... (130 more);, 181 disease states: normal, acute myeloid leukemia, ... (179 more);, 78 cell types 397 cell lines 24 compound treatments and 89 other conditions.
Synonyms NMYC, N-myc, bHLHe37
Orthologs Mycs (Mus musculus)   MYCN (Bos taurus)   MYCN (Gallus gallus)   mycn (Danio rerio)   Q4H361_CIOIN (Ciona intestinalis)   Mycn (Mus musculus)   Mycn (Rattus norvegicus)   Mycs (Rattus norvegicus)   mycn (Xenopus laevis)   MYCN (Canis familiaris)   (Compare orthologs)
Gene Ontology Term DNA binding, protein binding, regulation of transcription, DNA-dependent, transcription, DNA-dependent, positive regulation of transcription from RNA polymerase II promoter, nucleus, chromatin, regulation of transcription from RNA polymerase II promoter, positive regulation of mesenchymal cell proliferation, embryonic skeletal system morphogenesis, positive regulation of cell death, cartilage condensation, branching morphogenesis of a tube, embryonic digit morphogenesis, lung development, sequence-specific DNA binding transcription factor activity, negative regulation of reactive oxygen species metabolic process
InterPro Term Tscrpt_reg_Myc, Tscrpt_reg_Myc_N, HLH_DNA-bd
UniProt Accession Q9UMQ5, Q53XS5, P04198, Q7Z7Q9, B4DRZ1
Gene-Disease Assocation FEINGOLD SYNDROME
Search EB-eye ENSG00000134323
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-GEOD-6573, E-MEXP-1251, ... (23 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-2450, E-MTAB-62, ... (30 experiments)

Factor Value U/D Experiments
MCF-7
1
3
E-GEOD-19639, E-GEOD-3529, E-GEOD-20081, E-GEOD-5823
HCC1143
2
E-MTAB-37, E-MTAB-62
HL-60
2
E-GEOD-24147, E-GEOD-5258
Jurkat
2
E-GEOD-1880, E-MTAB-62
SW480
2
E-MEXP-1014, E-GEOD-18005
HT1376
1
E-MTAB-37
391 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-500, E-GEOD-21668, E-GEOD-3920, E-MEXP-750, ... (42 experiments)

Factor Value U/D Experiments
human embryonic stem cell
3
E-GEOD-18147, E-GEOD-20033, E-GEOD-18265
endothelial cell
1
3
E-GEOD-19240, E-GEOD-96, E-GEOD-3998, E-GEOD-3920
2
2
E-TABM-130, E-TABM-145
embryonic stem cell
2
E-MEXP-930, E-GEOD-2248
induced pluripotent stem cell
2
E-GEOD-18147, E-GEOD-18265
stromal cell
1
2
E-GEOD-10797, E-GEOD-1460, E-GEOD-3998
72 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-GEOD-1577, E-TABM-15, ... (55 experiments)

Factor Value U/D Experiments
lung adenocarcinoma
3
E-MTAB-37, E-MTAB-62, E-MEXP-231
colon carcinoma
2
E-MTAB-62, E-MTAB-37
choriocarcinoma
2
E-MTAB-37, E-MTAB-62
chronic myelogenous leukemia
2
E-MTAB-62, E-GEOD-5550
neuroblastoma
2
E-MTAB-37, E-MTAB-62
uterine fibroid
2
E-MTAB-62, E-GEOD-7307
175 more value(s).


Compound treatment

studied in E-GEOD-5824, E-GEOD-15811, E-GEOD-5099, E-MEXP-941, E-GEOD-5339, ... (17 experiments)

Factor Value U/D Experiments
none
4
E-GEOD-412, E-GEOD-5824, E-GEOD-7307, E-GEOD-5418
CNOT7+CNOT8
1
1
E-MEXP-2218
M-CSF
1
1
E-GEOD-5099
rapamycin
1
E-GEOD-5824
sapphyrin PCI-2054
1
E-GEOD-6400
unknown
1
E-GEOD-7307
18 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
1
E-GEOD-19519
tunicamycin
1
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd1a
studied in E-GEOD-22601

cd34
studied in E-GEOD-22601

cd4
studied in E-GEOD-22601

cd8
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21374, ... (9 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-MEXP-1251, ... (9 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-5999, E-GEOD-1614, E-GEOD-20033, E-GEOD-3140, ... (9 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-TABM-147, E-GEOD-1751

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643

Epiregulin elisa conc ng ml
studied in E-GEOD-5851

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-GEOD-7011, E-MTAB-73, E-MTAB-108, E-MEXP-2340 ... (5 experiments)

Genotype
studied in E-GEOD-22056, E-GEOD-2466, E-GEOD-17476, E-GEOD-22593, E-TABM-321, ... (9 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-GEOD-20504, E-MEXP-1446, E-MEXP-1103, ... (8 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Her2 status
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-302, E-GEOD-21653, E-TABM-276, E-GEOD-20194, ... (6 experiments)

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-1926, E-MEXP-2069, E-GEOD-16363, ... (30 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12108, E-MEXP-561, E-GEOD-980, E-GEOD-17400 ... (5 experiments)

Injury
studied in E-GEOD-19743

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Pcr vs rd
studied in E-GEOD-20194, E-GEOD-16716

Performer
studied in E-GEOD-2004, E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-1309, E-GEOD-1493, E-GEOD-21750, E-GEOD-1460, E-GEOD-17636, ... (7 experiments)

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Progression free survival of days
studied in E-GEOD-5851

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, ... (6 experiments)

Qpcr egfr dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-10797

Rna integrity
studied in E-TABM-325

RNAi
studied in E-GEOD-12438, E-GEOD-1676, E-MEXP-101, E-GEOD-3697, E-MEXP-1857 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-MEXP-70

Sex
studied in E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-11428

Stimulus or stress
studied in E-GEOD-7538

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276

Treatment
studied in E-GEOD-22152, E-GEOD-16837, E-GEOD-19246, E-GEOD-19815, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments 00 005
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4922

Tumor size
studied in E-GEOD-8167, E-GEOD-3494

Vehicle
studied in E-GEOD-5258

Processing time: 0.361 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM